Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Petosemtamab in Combination With Chemotherapy for Left-sided Colorectal Cancer
NCT07702032Phase 3Recruiting
- Sponsor
- Genmab
- Start
- Aug 2026
- Primary completion
- Jul 2029
- Countries
- 3
01
Overview
A Phase 3 trial of petosemtamab in colorectal cancer (CRC), sponsored by Genmab. Started Aug 2026; status: recruiting.
02
Drugs
petosemtamab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07702032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07702032.